Also trades as: HX (NASDAQ) · $vol 7M
AHG NASDAQ
Akso Health Group
1W: +53.3%
1M: +35.3%
3M: -24.8%
YTD: -28.1%
1Y: -31.6%
3Y: +12.8%
5Y: -37.8%
$1.15
+0.13 (+12.75%)
Weekly Expected Move ±20.7%
$1
$1
$1
$1
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$14M
-6.4% ▼
5Y CAGR: +51.1%
Gross Profit
-$11K
+96.0% ▲
Operating Income
-$4M
+97.6% ▲
Net Income
-$19M
+86.2% ▲
EPS (Diluted)
$-0.03
+93.8% ▲
EBITDA
-$2M
+8.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $6M | $13M | $2M | $15M | $14M |
| YoY Growth | +241.9% | +119.7% | -81.7% | +512.1% | -6.4% |
| Cost of Revenue | $5M | $12M | $2M | $15M | $14M |
| Gross Profit | $605K | $1M | $122K | -$282K | -$11K |
| Gross Margin | 10.1% | 9.6% | 5.1% | -1.9% | -0.1% |
| R&D Expenses | $421K | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3M | $16M | $9M | $4M | $4M |
| Operating Expenses | $4M | $16M | $9M | $166M | $4M |
| Operating Income | -$3M | -$14M | -$9M | -$166M | -$4M |
| Operating Margin | -54.3% | -108.2% | -357.8% | -1125.4% | -28.9% |
| Interest Expense | $804K | $0 | $0 | $0 | $0 |
| Income Before Tax | -$4M | -$13M | -$9M | -$166M | -$21M |
| Tax Expense | $93K | $18K | $25K | -$31M | -$2M |
| Net Income | -$17M | -$1M | -$9M | -$135M | -$19M |
| Net Margin | -280.8% | -10.3% | -391.8% | -913.4% | -135.0% |
| EPS (Diluted) | $-2.55 | $-0.06 | $-0.39 | $-0.48 | $-0.03 |
| EBITDA | -$3M | -$14M | -$9M | -$2M | -$2M |
| Shares Outstanding | 7M | 8M | 24M | 285M | 723M |